Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112707799A details a novel waste-to-value route for 3,4'-dichlorodiphenyl ether. Discover cost-effective synthesis and supply chain advantages for fine chemical manufacturing.
Patent CN109134312B reveals a high-yield synthesis of 2-phenylacrylonitrile using bicarbonate catalysis, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101328147A reveals a cost-effective Raney Nickel catalyzed route for Isopropylpyrazolone, offering significant supply chain advantages for API manufacturers.
Patent CN101704711A reveals solvent-free fluoroboric acid catalysis for high-purity 1,2-diol production, offering substantial cost reduction and supply chain reliability for global manufacturers.
Patent CN109232368A reveals one-step carbonylation route. Offers high yield and mild conditions for reliable intermediate supply chain optimization.
Advanced synthesis of 2-methylthio-4-pyrimidinone via patent CN114933567B. Cost-effective rilpivirine intermediate manufacturing with high purity and scalable supply chain solutions.
Novel metal-free photocatalytic route for diaryl ether derivatives. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN121022786A reveals a novel AmDH enzyme for high-purity chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113801015B details a palladium-catalyzed carboxylation method using CO2. This report analyzes cost reduction and supply chain reliability for fine chemical manufacturing.
Discover the solvent-free synthesis of imidazophenanthroline compounds. Enhance supply chain reliability and reduce manufacturing costs with our advanced green chemistry solutions.
Advanced acidolysis method for high-purity Olaparib intermediate. Reduces impurities and enhances scalability for API manufacturing.
Novel dehydroabietylamine-based catalyst enables high-yield Morita-Baylis-Hillman reactions with up to 94% yield and 89% ee, offering cost-effective asymmetric synthesis solutions.
Novel Lewis acid catalysis enables high-purity ornidazole enantiomers with simplified workflow and substantial supply chain cost advantages for global buyers.
Patent CN103764664B reveals an acetone-based purification method for Erythromycin Thiocyanate, offering superior purity and cost reduction in API manufacturing.
Discover a scalable, eco-friendly synthesis route for 4-acetoxy-2-azetidinone intermediates. Eliminate toxic reagents and reduce manufacturing costs for carbapenem production.
Novel preparation method for Voriconazole using optimized L(-)-camphor-10-sulfonic acid resolution. Reduces reagent consumption and simplifies purification for high-purity API manufacturing.
Novel patent CN103402973A details a shikimic acid-free route for Tamiflu precursors, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Novel Rh-catalyzed route for high-purity gamma-butyrolactone derivatives with superior enantioselectivity and scalable manufacturing capabilities for global pharma supply chains.
Novel seven-step route improves yield significantly. Cost-effective manufacturing for pharmaceutical intermediates. Reliable supply chain partner for steroid hormones.
Patent CN117659018A details novel chiral ligands enabling high-purity pharmaceutical intermediate manufacturing with significant cost reduction and supply chain reliability.